Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 12:0_14:0_18:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST004118 AN006828 Lipidomics on Hep3B Cells Overexpressing CGI-158 and PNPLA2 Cultured cells Human Liver disease; Cancer Amgen LC-MS
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003897 AN006400 Postprandial Plasma Lipidomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Cardiovascular disease Nanjing Medical University Other
ST003897 AN006400 Postprandial Plasma Lipidomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Diabetes Nanjing Medical University Other
ST003897 AN006400 Postprandial Plasma Lipidomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Obesity Nanjing Medical University Other
ST003894 AN006397 Postprandial Plasma Lipidomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Cardiovascular disease Nanjing Medical University Other
ST003894 AN006397 Postprandial Plasma Lipidomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Diabetes Nanjing Medical University Other
ST003894 AN006397 Postprandial Plasma Lipidomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Obesity Nanjing Medical University Other
ST003792 AN006234 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Maple syrup urinary disease University of Colorado Denver LC-MS
ST003792 AN006234 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Metabolic disease University of Colorado Denver LC-MS
ST003760 AN006174 Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003758 AN006170 Untargeted lipidomics of gemcitabine-resistant cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003694 AN006061 FOLFIRINOX effects on lipidomics in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003637 AN005973 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003632 AN005965 Dysregulated Lipid Metabolism in African American Women Who Experienced Cardiometabolic Complications of Pregnancy Blood Human Preeclampsia Emory University LC-MS
ST003629 AN005962 Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells T-cells Human Brain disease Leibniz Institute for Plasma Science and Technology LC-MS
ST003364 AN005511 Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease Aortic valve tissue Human Heart disease Technical University Dresden LC-MS
ST003184 AN005229 A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis - tumor lipidomics Tumor cells Mouse Cancer University of Colorado Anschutz Medical Campus LC-MS
ST002967 AN004875 Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids Cultured cells Human Cancer Ohio State University LC-MS
ST002911 AN004780 LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation Lung Mouse Tuberculosis Universidad CEU San Pablo LC-MS
ST002787 AN004534 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002713 AN004398 Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics Cultured cells Human Cancer University of Colorado Denver LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002283 AN003730 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire LC-MS
ST002243 AN003661 Lipidomics analysis of Friedreich's ataxia (FRDA) (part II) Blood Human Friedreichs Ataxia University of Pennsylvania LC-MS
ST002162 AN003542 CFAP418 participates in membrane-associated cellular processes through binding lipids during ciliogenesis Eye tissue Mouse Eye disease University of Utah - Metabolomics Core LC-MS
ST002162 AN003543 CFAP418 participates in membrane-associated cellular processes through binding lipids during ciliogenesis Eye tissue Mouse Eye disease University of Utah - Metabolomics Core LC-MS
  logo